Yolanda Ohene1, Ian F. Harrison1, David L. Thomas2,3,4, Mark F. Lythgoe 1, and Jack A. Wells 1
1Centre for Advanced Biomedical Imaging, UCL, London, United Kingdom, 2Neuroradiological Academic Unit, UCL Queen Square Institute of Neurology, UCL, London, United Kingdom, 3Dementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, United Kingdom, 4Wellcome Centre for Humans Neuroimaging, UCL Queen Square Institute of Neurology, UCL, London, United Kingdom
Synopsis
Multi-TE ASL technique detects a significant increase (32%) in blood-brain interface (BBI) permeability in the ageing brain. The change in BBI water permeability is associated with a marked increase (1.9 ± 0.4 fold) in expression of PDGFRβ, an index of pericyte coverage, and changes to aquaporin water channels and their anchoring proteins in the ageing brain. This technique is a promising non-invasive tool to measure age-related changes to the BBI, that may play a mechanistic role in the pathogenesis of neurodegenerative conditions.
Introduction
There
is increasing evidence to suggest that changes to the integrity of the
blood-brain interface (BBI) is an early event in neurodegenerative conditions,
such as Alzheimer’s Disease (AD) [1-3].
BBI dysfunction is associated with inflammation, loss of tight junctions,
pericyte coverage and changes to astrocytic aquaporin-4 (AQP4) water channels,
potentially causing an increase in BBI permeability [4]. BBI
permeability is often assessed using DCE-MRI, which uses relatively large
contrast agents, that may only detect gross damage to the BBI [1]. Given that ageing is the biggest risk factor
for AD [5], aged mice may
represent a model of early neurodegenerative processes in age-related cognitive
decline [6].
Non-invasive multiple echo time (multi-TE) ASL uses the endogenous vascular
water as a tracer, to measure the rate of vascular water moving into the
extravascular brain tissue as an index of BBI permeability to water. We
hypothesize that BBI permeability to water may be increased in the aged mouse,
due to dysfunction to the components of the BBI that can occur during the
ageing process. Detecting changes in BBI permeability to water in the aged
mouse brain could help to understand early neurodegenerative processes that
may be a preclinical precursor of AD. Methods
Images were acquired using
a 9.4T Bruker imaging system (BioSpec) in two groups of C57Bl/6JRj mice, aged
mice at 27±1 month old (n = 8) and adult mice at 7±1 month old (n = 9). Imaging
parameters were: inflow times (TI) = 800 ms and 1500 ms; echo times (TE) = 8,
10, 12, 15, 18, 23, 30, 40, 50, 65 ms; slice thickness = 2 mm; FOV = 25x25 mm; matrix size = 64x64; repetitions
= 10. All mice were anesthetised with 2% isoflurane in a mixture of
1.0L/min medical air, and adjusted to
maintain respiration at ~100bpm. Multi-TE ASL data was processed with Matlab R2018
(Mathworks), using protocol shown in Figure
1, which uses a bi-exponential (intravascular (IV) and extravascular (EV))
model for ASL signal, ΔM = ΔMIV exp((TE)/(T2IV)) + ΔMEV exp((TE)/(T2EV)) (Eq.1) to calculate the mean cortical exchange time (Texw) as a surrogate index of the BBI water permeability [7]. CBF was determined using the general kinetic model.
For quantification of BBI
molecular components, mRNA expression of aquaporin-4 water channels (Aqp4), α-syntrophin
protein (SNTA1) for anchoring of AQP4 to BBI, platelet-derived growth
factor receptor-β (PDGFRβ), as
an index of pericytes coverage and the tight junction proteins, occludin (Occl)
and claudin-5 (Cld5) were measured. The cortical regions of the same
aged mice (n = 7) and adult mice (n = 7) were dissected, total RNA was extracted
and converted to cDNA using RNeasy® Plus Microkit/ QuantiTect® Reverse Transcription Kit
(Qiagen). TaqMan® Gene Expression assays were used for each BBI
component, normalising to housekeeper genes (ACTB and GAPDH).
Quantification of mRNA expression level, for each BBI component was assessed by
the 2–∆∆Ct method [8].Methods
The
mean cortical exchange time was significantly (32%) lower in the aged mice (335
± 70 ms) relative to the adult mice (440 ± 75 ms) (p = 0.017), Figure 2. There were no marked differences in CBF in aged mice (188 ± 61 ml/100g/min) compared to the
adult mice (191 ± 71 ml/100g/min), p = 0.935. The changes to the mRNA
expression of the molecular components of the BBI of the aged mice relative to
the adult mice are presented in Figure 3. We report an increase, though non-significant, to the mRNA expression of
AQP4 in the aged mice (2.1 ± 0.9 fold), p = 0.083. There was a significant
decrease in SNTA1 mRNA expression in the aged mice (0.14 ± 0.09 fold), p =
0.012. There is a marked increase in mRNA expression of PDGFRβ
(1.9 ± 0.4 fold) in the aged mice, p = 0.015. mRNA expression of tight
junction proteins occludin (1.4 ± 0.8 fold) and claudin-5 (1.5 ± 0.6 fold) appear
to be relatively maintained in ageing brain, p > 0.999 and p = 0.645
respectively.Discussion
Multi-TE
ASL detected a significantly lower exchange time as an index of increased BBI
water permeability in the cortical region of the ageing mouse brain. This
represents the first measurement of changes to BBI permeability to water in the
ageing brain. The increase in BBI water permeability may be due to the increase
in the expression of pericytes marker PDGFRβ. Recent
studies have reported an increase in soluble PDGFRβ to reflect pericyte injury at the BBI and correlate
with the extent of cognitive decline in early MCI patients [3]. The increase in water permeability in the
ageing brain may also be associated with the mean increase in AQP4 water
channel (although conversely this concurs with significant decrease in protein,
SNTA1 that anchors the AQP4 to the BBI). The changes to AQP4 and SNTA1 suggest
dysfunction of AQP4 channels, which has previously been associated with the
severity cognitive decline in AD [9].Conclusion
Non-invasive multi-TE ASL can detect an increase in BBI permeability to
water in the ageing mouse brain. This technique may be used to better
understand the changes occurring at the BBI that may play a key mechanistic role in the pathogenesis of neurodegenerative conditions. Acknowledgements
This work is supported by the Medical Research Council (MR/K501268/1), the EPSRC-funded UCL Centre for Doctoral Training in Medical Imaging(EP/L016478/1) and the UCL Leonard Wolfson Experimental Neurology Centre (PR/YLR/18575), together with the Wellcome Trust and Royal Society.References
[1] Montagne, A., S. R. Barnes, M. D. Sweeney, M. R. Halliday, A. P. Sagare, Z. Zhao, A. W. Toga, R. E. Jacobs, C. Y. Liu, L. Amezcua, M. G. Harrington, H. C. Chui, M. Law and B. V. Zlokovic (2015). "Blood-brain barrier breakdown in the aging human hippocampus." Neuron 85(2): 296-302.
[2] van de Haar, H. J., S. Burgmans, J. F. Jansen, M. J. van Osch, M. A. van Buchem, M. Muller, P. A. Hofman, F. R. Verhey and W. H. Backes (2016). "Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease." Radiology 281(2): 527-535.
[3] Nation, D. A., M. D. Sweeney, A. Montagne, A. P. Sagare, L. M. D’Orazio, M. Pachicano, F. Sepehrband, A. R. Nelson, D. P. Buennagel, M. G. Harrington, T. L. S. Benzinger, A. M. Fagan, J. M. Ringman, L. S. Schneider, J. C. Morris, H. C. Chui, M. Law, A. W. Toga and B. V. Zlokovic (2019). "Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction." Nature Medicine 25(2): 270-276.
[4] Erdő, F., L. Denes and E. de Lange (2017). "Age-associated physiological and pathological changes at the blood-brain barrier: A review." Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 37(1): 4-24.
[5] Farrall, A. J. and J. M. Wardlaw (2009). "Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis." Neurobiol Aging 30(3): 337-352.
[6] Ahlemeyer, B., S. Halupczok, E. Rodenberg-Frank, K. P. Valerius and
E. Baumgart-Vogt (2018). "Endogenous Murine Amyloid-beta Peptide Assembles
into Aggregates in the Aged C57BL/6J Mouse Suggesting These Animals as a Model
to Study Pathogenesis of Amyloid-beta Plaque Formation." J Alzheimers
Dis 61(4): 1425-1450.
[7] Ohene, Y., I. F. Harrison, P. Nahavandi, O. Ismail, E. V. Bird, O. P. Ottersen, E. A. Nagelhus, D. L. Thomas, M. F. Lythgoe and J. A. Wells (2019). "Non-invasive MRI of brain clearance pathways using multiple echo time arterial spin labelling: an aquaporin-4 study." NeuroImage 188: 515-523.
[8] Livak, K. J. and T. D. Schmittgen (2001). "Analysis of relative
gene expression data using real-time quantitative PCR and the 2(-Delta Delta
C(T)) Method." Methods 25(4):
402-408.
[9] Zeppenfeld, D. M., M. Simon, J. D. Haswell, D.
D’Abreo, C. Murchison, J. F. Quinn, M. R. Grafe, R. L. Woltjer, J. Kaye and J.
J. Iliff (2017). "Association of Perivascular Localization of Aquaporin-4
With Cognition and Alzheimer Disease in Aging Brains." JAMA Neurology
74(1): 91